Enhertu shows promising results for HER2-low and HER2-ultralow metastatic breast cancer

https://www.facingourrisk.org/XRAY/metastatic-breast-cancer-treatment-after-endocrine-therapy

Full article: https://www.nejm.org/doi/full/10.1056/NEJMoa2407086

Recent study results show that a new targeted treatment works better than standard chemotherapy for people with metastatic hormone receptor-positive breast cancers with low or ultralow HER2 status. (Posted 5/15/25)

Questions To Ask Your Health Care Provider

Have I had HER2 testing? What was the result?
Was the most current scoring approach used from my HER2 testing?
Do you recommend testing for HER2 again?
Is Enhertu a treatment option for me? Why or why not?
What are the risks and benefits of Enhertu treatment? What are the possible side effects?

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.